• Shuffle
    Toggle On
    Toggle Off
  • Alphabetize
    Toggle On
    Toggle Off
  • Front First
    Toggle On
    Toggle Off
  • Both Sides
    Toggle On
    Toggle Off
  • Read
    Toggle On
    Toggle Off
Reading...
Front

Card Range To Study

through

image

Play button

image

Play button

image

Progress

1/12

Click to flip

Use LEFT and RIGHT arrow keys to navigate between flashcards;

Use UP and DOWN arrow keys to flip the card;

H to show hint;

A reads text to speech;

12 Cards in this Set

  • Front
  • Back
  • 3rd side (hint)
Chronic Myeloproliferative Disorder
t9;22
(fusion of BCR on C22 w/ regions of ABL on C9)
Blood smear: PMS in various stages of maturation; maybe increased baso/eos; not much dysplasia
Polycythemia Vera
JAK2 (non-specific), no t9;22
Blood smear: increase in red cell mass and hct; normochromic, normocytic RBCS, maybe w/ neutrophilia/basophilia, thrombocytosis
Primary Myelofibrosis
JAK2 (non-specific), no t9;22
BS:Fibrotic stage: Leukoerythroblastosis and tear drop RBC
Essential Thrombocythemia
JAK 2 in 40-50%
Bone marrow biopsy shows increased number of megakaryocytes
Cutaneous Mastocytosis
Mast cells + for CD117
Refractory anemia with isolated _____
5q deletion
Greater than 5% blasts in blood; hypercellular BM; dysplasia is uncommon
Myeloid Ags
CD13, 33, 117
Immature markers on blasts
CD34, HLA-DR
AML with recurrent genetic Abnormalities: disruption of normal function of core binding factor (CBF) by chimeric protein
t(8;22)(q22;22)
When detected, even cases wih <20% blasts should be considered AML
AML; fusion of CBFbeta and MYH11 which disrupts core binding factor
inversion 16(p13;q22)
Acute Promyelocytic Leukemia
t(15;17)(q22;q12)
PML and RARA genes involved
CD13, CD22 pos, CD34 neg (more mature cell)
Increased PROmyelocytes:
medical emergency... ass. with DIC
AML with therapy related leukemia after treatment with DNA topoisomerase II inhib
11q23 (MLL chromosome)
gingival hypertrophy~!